Acta Neurologica Scandinavica

Article	Citations
Neurological Manifestations of COVID‐19: A systematic review and current update	281
Neurological side effects of SARS‐CoV‐2 vaccinations	100
The potential neurological effect of the COVID‐19 vaccines: A review	81
Epilepsy in time of COVID‐19: A survey‐based study	70
Effect of COVID‐19 pandemic on stroke admission rates in a Norwegian population	56
The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use	49
Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis	43
Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis	33
Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials	32
Glymphatic dysfunction in isolated REM sleep behavior disorder	31
In‐hospital acute stroke workflow in acute stroke – Systems‐based approaches	30
COVID‐19 presentations and outcome in patients with epilepsy	29
Blood biomarkers for Alzheimer's disease and related disorders	28
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis	28
Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review	27
Parkinson’s disease and intensive exercise therapy — An updated systematic review and meta‐analysis	27
Refractory migraine profile in CGRP‐monoclonal antibodies scenario	26
Neurophysiological impairments in multiple sclerosis—Central and peripheral motor pathways	25
Air pollution, a possible risk factor for multiple sclerosis	25
EEG and Coma Recovery Scale‐Revised prediction of neurological outcome in Disorder of Consciousness patients	25
Blood biomarkers in ALS : challenges, applications and novel frontiers	24
SARS‐CoV‐2 vaccines are not free of neurological side effects	24
Trigeminal neuralgia in multiple sclerosis: Prevalence and association with demyelination	24
Persistent olfactory dysfunction after COVID‐19 is associated with reduced perfusion in the frontal lobe	24
Pyridoxine, folate and cobalamin for migraine: A systematic review	24

Prevalence of non‐motor symptoms and their association with quality of life in cervical dystonia	22
Medication adherence/persistence among patients with active multiple sclerosis in Finland	22
Generalized status epilepticus as a possible manifestation of COVID‐19	21
Multiple cranial nerve palsies following COVID‐19 vaccination—Case report	21
A meta‐analysis of collateral status and outcomes of mechanical thrombectomy	20
Vagus nerve stimulation in patients with Lennox‐Gastaut syndrome: A meta‐analysis	20
Military service and related risk factors for amyotrophic lateral sclerosis	19
Systolic blood pressure variability following endovascular thrombectomy and clinical outcome in acute ischemic stroke: A meta‐analysis	19
Microglia and immunotherapy in Alzheimer’s disease	19
Guillain‐Barre syndrome following COVID‐19 vaccines: A scoping review	19
Multiple sclerosis and COVID‐19: The Swedish experience	19
Impacts of the COVID‐19 pandemic on Iranian patients with epilepsy	19
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials	18
Neurological manifestations as primary presentation of COVID‐19 in hospitalized patients	17
Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID‐19 pandemic	17
Leukoaraiosis severity and post‐reperfusion outcomes in acute ischaemic stroke: A meta‐analysis	17
Non‐motor symptoms in patients with autosomal dominant spinocerebellar ataxia	17
Drug treatments in patients with cardiac diseases and epilepsy	17
Non‐pharmacological therapies for pain management in Parkinson's disease: A systematic review	17
Evidence‐based anti‐seizure monotherapy in newly diagnosed epilepsy: A new approach	16
Epilepsy treatment gap in Sub‐Saharan Africa: Meta‐analysis of community‐based studies	16
Effectiveness of clinical exome sequencing in adult patients with difficult‐to‐diagnose neurological disorders	16
Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report	15
A nomogram to predict mechanical ventilation in Guillain‐Barré syndrome patients	15
Risk factors for minor hallucinations in Parkinson's disease	15
Myasthenia gravis and COVID‐19: A case series and comparison with literature	15
Identifying epilepsy psychiatric comorbidities with machine learning	15
People with epilepsy still feel stigmatized	15
Potassium channels and epilepsy	14
Prevalence and risk of thyroid diseases in myasthenia gravis	14
Socioeconomic consequences of multiple sclerosis—A systematic literature review	14
Accuracy of NIH Stroke Scale for diagnosing aphasia	14
Epilepsy and lockdown: A survey of patients normally attending a Spanish centre	14
Mechanical thrombectomy with or without thrombolysis: A meta‐analysis of RCTs	14
Blood biomarkers in epilepsy	13
Myositis‐specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies	13
Heart rate variability in frontal lobe epilepsy: Association with SUDEP risk	13
Clinical features and outcomes of benign recurrent vertigo: A longitudinal study	13
Blood biomarkers of peripheral neuropathy	13
Supervised exercises versus telerehabilitation. Benefits for persons with multiple sclerosis	13
DNA methylation of the 5′‐UTR DAT 1 gene in Parkinson's disease patients	13
CTP‐guided reperfusion therapy in acute ischemic stroke: a meta‐analysis	13
Eslicarbazepine acetate in post‐stroke epilepsy: Clinical practice evidence from Euro‐Esli	12
In‐hospital systems interventions in acute stroke reperfusion therapy: a meta‐analysis	12
Quality of life long after temporal lobe epilepsy surgery	12
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis	12
Aquatic therapy in stroke rehabilitation: systematic review and meta‐analysis	12
Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis	12
Long‐term prognosis related to deep sedation in refractory status Epilepticus	12
Neurological symptoms and blood neurofilament light levels	12

Comorbidities in older patients with myasthenia gravis — Comparison between early‐ and late‐onset disease	12
Machine learning analysis of heart rate variability to detect delayed cerebral ischemia in subarachnoid hemorrhage	12
Association between inflammatory response and outcome after subarachnoid haemorrhage	12
Outcomes in three cases after brivaracetam treatment during pregnancy	12
Therapy delay in status epilepticus extends its duration and worsens its prognosis	11
Small fiber neuropathy	11
Parkinson’s disease in Sweden—resource use and costs by severity	11
Changes in multiple sclerosis epidemiology in Finland over five decades	11
Seizure freedom as an outcome in epilepsy treatment clinical trials	11
Meta‐analysis of melatonin levels in cluster headache—Review of clinical implications	11
Early identification of epilepsy surgery candidates: A multicenter, machine learning study	11
Advances in sudden unexpected death in epilepsy	11
Fatigue 7 years post‐stroke: Predictors and correlated features	11
Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis	11
Efficacy of lacosamide and phenytoin in status epilepticus: A systematic review	11
Upregulated serum miR‐128‐3p in progressive and relapse‐free multiple sclerosis patients	11
Standardized mortality ratios in multiple sclerosis: Systematic review with meta‐analysis	11
Ketamine in adult super‐refractory status epilepticus: Efficacy analysis on a prospective registry	10
Pregnancy and neurologic complications of COVID‐19: A scoping review	10
Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial	10
Temporal lobe epilepsy with amygdala enlargement: A systematic review	10
Neurofunctional outcomes in patients with anti‐leucine‐rich glioma inactivated 1 encephalitis	10
Intravenous sodium valproate for acute migraine in the emergency department: A meta‐analysis	10
Brain networks in migraine with and without aura: An exploratory arterial spin labeling MRI study	10
Ischemic stroke patients with prestroke dependency: Characteristics and long‐term prognosis	10
Plasma total tau predicts executive dysfunction in Parkinson's disease	10
Gamma knife surgery in the treatment of intracanalicular vestibular schwannomas	10
Progressive external ophthalmoplegia associated with novel MT ‐ TN mutations	10
Myelin‐associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson's disease	10
Functional outcome and quality of life after meningioma surgery: a systematic review	9
Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementia	9
Efficacy of high‐intensity aerobic exercise on common multiple sclerosis symptoms	9
Diversified social cognition in temporal lobe epilepsy	9
Dynamic gray matter and intrinsic activity changes after epilepsy surgery	9
Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis	9
Meta‐analysis of association between migraine and risk of dementia	9
Physical activity and cognition in young‐onset Parkinson’s disease	9
Quality of life in patients with glioblastoma and their relatives	9
Neuropsychological screening in the acute phase of cerebrovascular diseases	9
Verbal and spatial memory spans in mild cognitive impairment	9
Potential role of brivaracetam in pediatric epilepsy	9
Electrodiagnostic findings in patients with non‐COVID‐19‐ and COVID‐19‐related acute respiratory distress syndrome	9
Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate	9
Birth characteristics and risk of febrile seizures	9
Treatment satisfaction with calcitonin gene‐related peptide monoclonal antibodies as a new patient‐reported outcome measure: A real‐life experience in migraine	9
Neuromodulation in drug‐resistant epilepsy: A review of current knowledge	9
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke	9
Seizure outcome trajectories in a well‐defined cohort of newly diagnosed juvenile myoclonic epilepsy patients	8
Critical illness polyneuromyopathy: Functional impact after severe acquired brain injuries	8
Clinical outcomes and safety profile of Tenecteplase in wake‐up stroke	8
Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease	8
Basal IL‐6 and S100b levels are associated with infarct volume	8
The evidence for switching dibenzazepines in people with epilepsy	8
Severe neurological nicotine intoxication by e‐cigarette liquids: Systematic literature review	8
Effects of transdermal nicotine delivery on cognitive outcomes: A meta‐analysis	8
Optical coherence tomography in patients with Wilson's disease	8
Is wearing a face mask safe for people with epilepsy?	8
Medium‐term effects of COVID‐19 pandemic on epilepsy: A follow‐up study	8
Impact of comorbidities on the disability progression in multiple sclerosis	8
Association of consciousness impairment and mortality in people with COVID‐19	8
Seizure freedom and plasma levels of newer generation antiseizure medications	8
European perspective of perampanel response in people with Intellectual Disability	8
Medical complications and outcome after endovascular therapy for acute ischemic stroke	8
The impact of social capital on patients with multiple sclerosis	8
Initial cognitive impairment predicts shorter survival of patients with glioblastoma	8
Blood based biomarkers for movement disorders	8
Brain networks in patients with isolated or recurrent transient global amnesia	8
Genotype‐phenotype analysis of MT‐ATP6 ‐associated Leigh syndrome	7
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy	7
Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review	7
Motor Band Sign in Motor Neuron Diseases Using Magnetic Resonance Imaging: A Systematic Review	7
STN‐DBS affects language processing differentially in Parkinson's disease: Multiple‐case MEG study	7
Activities of daily living in myotonic dystrophy type 1	7
Deep brain stimulation of the subthalamic nucleus for epilepsy	7
Incidence and mortality in adults with epilepsy in northern Spain	7
Stroke admissions and revascularization treatments in Denmark during COVID‐19	7
Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy‐related inflammation	7
Circulating levels of vascular endothelial growth factor and post‐stroke long‐term functional outcome	7
Impaired neck motor control in chronic whiplash and tension‐type headache	7
Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta‐analysis	7

Swedish guidelines for device‐aided therapies in Parkinson's disease —Economic evaluation and implementation	7
Systemic thrombolysis in ischaemic stroke patients with COVID‐19	7
Help‐seeking behaviour and subsequent patient and system delays in stroke	7
Associations between seizures and MRI in patients with anti‐NMDAR encephalitis	7
Blood‐based biomarkers and traumatic brain injury—A clinical perspective	7
Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus	7
The Prehospital Stroke Score and telephone conference: A prospective validation	7
Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study	7
Prevalence and development of idiopathic normal pressure hydrocephalus: A 16‐year longitudinal study in Japan	7
EEG patterns associated with present cortical SSEP after cardiac arrest	7
Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta‐analysis	7
Bone health, intellectual disability and epilepsy: An observational community‐based study	7
Retinal thinning and brain atrophy in early MS and CIS	7
Step‐rate threshold for physical activity intensity in Parkinson’s disease	7
Epidemiology of multiple sclerosis in Santiago de Compostela (Spain)	7
Epidemiology of status epilepticus in a non‐urban area in Switzerland	7
Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy	7
Clinical characteristics of GAD 65‐associated autoimmune encephalitis	7
Time course of 75%–100% efficacy response of adjunctive brivaracetam	7
The impact of COVID‐19 in Dravet syndrome: A UK survey	7
Neurological side effects of COVID‐19 vaccines are rare	7
Identification of focal epilepsy by diffusion tensor imaging using machine learning	7
Definition of drug‐resistant epilepsy: A reappraisal based on epilepsy types	7
Epilepsy in the time of COVID‐19	6
S100B and neuron‐specific enolase levels in episodic and chronic migraine	6
Seizure detection based on wearable devices: A review of device, mechanism, and algorithm	6
Surgery in intractable epilepsy—physicians' recommendations and patients' decisions	6
Non‐motor symptoms are associated with midline tremor in essential tremor	6
Non‐convulsive seizures and non‐convulsive status epilepticus in neuro‐intensive care unit	6
Fluid biomarkers in stroke: From animal models to clinical care	6
Plantar stimulation alters brain connectivity in idiopathic Parkinson's disease	6
Repeated infusion of autologous adipose tissue‐derived stem cells for Parkinson's disease	6
Response to first antiseizure medication in patients diagnosed with epilepsy	6
Cognitive change after DBS in refractory epilepsy: A randomized‐controlled trial	6
Effect and efficacy of lifestyle interventions as secondary prevention	6
Early post‐traumatic seizures in hospitalized patients with traumatic brain injury	6
Onset of efficacy and adverse events during Cenobamate titration period	6
Sonographic pattern of median nerve enlargement in Hansen's neuropathy	6
Caffeinated drinks, fruit juices, and epilepsy: A systematic review	6
Epilepsy in adult patients with tuberous sclerosis complex	6
Withdrawal failure in patients with chronic migraine and medication overuse headache	6
Effects of robotic rehabilitation on recovery of hand functions in acute stroke: A preliminary randomized controlled study	6
Topiramate, acupuncture, and BoNT‐A for chronic migraine: a network meta‐analysis	6
Poststroke epilepsy incidence, risk factors and treatment: German claims analysis	6
Switching antiepileptic drugs to once‐daily dosing regimens in epilepsy patients	6
Prehospital recognition of stroke is associated with a lower risk of death	6
Relapse factors of patients of anti‐N‐methyl‐D‐aspartate receptor encephalitis	6
EEG spindles integrity in critical care adults. Analysis of a randomized trial	6
Narcolepsy treatment in Sweden: An observational study	6
Fetal posterior cerebral artery configurations in an ischemic stroke versus an unselected hospital population	6
Sports and trauma as risk factors for Motor Neurone Disease: New Zealand case–control study	6
Cerebrospinal fluid CD4 + /CD8 + ratio in diagnosing neurosarcoidosis	6
In vivo microstructural white matter changes in early spinocerebellar ataxia 2	6
Teleneurology in Parkinson's disease: A step‐by‐step video guide	6
Cannabinoids in multiple sclerosis: A neurophysiological analysis	6
Changing epidemiology of traumatic brain injury among the working‐aged in Finland: Admissions and neurosurgical operations	5
Retinal changes associated with multivitamin deficiency before and after supplementation	5
Cortical remodeling before and after successful temporal lobe epilepsy surgery	5
Epilepsy care and COVID‐19: A cross‐sectional online survey from Lithuania	5
Increased level of LIGHT/TNFSF14 is associated with survival in aneurysmal subarachnoid hemorrhage	5
Diplopia in Parkinson's disease: Indication of a cortical phenotype with cognitive dysfunction?	5
Impact of ictal subtraction SPECT and PET in presurgical evaluation	5
Acute stroke care during the first phase of COVID‐19 pandemic in Norway	5
Eptinezumab for migraine prevention in patients 50 years or older	5
Left ventricle end‐systolic elastance, arterial‐effective elastance, and ventricle‐arterial coupling in Epilepsy	5
Abnormal blood oxygen level‐dependent fluctuations and remote connectivity in sleep‐related hypermotor epilepsy	5
Driving eligibility: Implications of studies on seizure recurrence risk	5
End‐of‐life care in amyotrophic lateral sclerosis: A comparative registry study	5
40‐Hz auditory stimulation for intracranial interictal activity: A pilot study	5
Acute‐onset binocular diplopia in neurological unit: Aetiological factors and diagnostic assessment	5
Genetic analysis reveals novel variants for vascular cognitive impairment	5
Potential mechanism of SARS‐CoV ‐2‐associated central and peripheral nervous system impairment	5
Paediatric sudden unexpected death in epilepsy: A parental report cohort	5
Treatment of occipital neuralgia using onabotulinum toxin A	5
Greater occipital nerve block for chronic migraine patients: A meta‐analysis	5
Theory of mind: A clue for the interpretation of functional movement disorders	5
Stroke after COVID‐19 vaccination	5
Multiple sclerosis among first‐ and second‐generation immigrant groups in Sweden	5
Perceived and actual changes in gait balance after CSF shunting in idiopathic normal pressure hydrocephalus	5
Levetiracetam as first‐line monotherapy for Idiopathic Generalized Epilepsy in women	5
Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin	5
Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes	5
Subjective postural vertical in Parkinson's disease with lateral trunk flexion	5
Clinical significance of bilateral epileptiform discharges in temporal lobe epilepsy	5
Minor hallucinations in isolated rapid eye movement sleep behavior disorder indicative of early phenoconversion: A preliminary study	5
Dopamine transporter SPECT imaging in corticobasal syndrome: A peak into the underlying pathology?	4
Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy	4
Balance and physical functioning in Spinocerebellar ataxias 3 and 10	4
Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County	4
Eslicarbazepine acetate response in intellectual disability population versus general population	4
Direct economic burden of patients with tuberculous meningitis in western China	4
Long‐term outcome of 200 patients referred to a first seizure clinic	4
Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy	4
Difficulties in the prehospital assessment of patients with TIA/stroke	4
Long‐term effects of zonisamide in adult patients with intellectual disability	4